Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of danshinolic acid A in preparation of medicines for preventing and treating AIDS encephalopathy

A technology of AIDS encephalopathy and salvianolic acid, applied in the application field of drugs for the prevention and treatment of nerve damage caused by HIV-1 Tat protein

Inactive Publication Date: 2014-06-18
HENAN UNIVERSITY
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are no related reports about the protection of salvia miltiorrhiza or salvianolic acid A on nerve damage caused by HIV-1 Tat protein or its application in HAND treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of danshinolic acid A in preparation of medicines for preventing and treating AIDS encephalopathy
  • Application of danshinolic acid A in preparation of medicines for preventing and treating AIDS encephalopathy
  • Application of danshinolic acid A in preparation of medicines for preventing and treating AIDS encephalopathy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] (1) Main reagents, cells and instruments

[0028] HIV-1Tat protein was purchased from Shenzhen Baiwansen Bio-Trade Co., Ltd. (Prospec, USA, batch number: 212PCLADEB28). Salvianolic acid A (batch number: 96574-01-5) and tanshinone IIA (batch number: 568-72-9) were purchased from Zhengzhou Fengyao Agriculture Co., Ltd. Rat adrenal pheochromoma cell line (PC12) was purchased from Shanghai Institute of Cells, Chinese Academy of Sciences. MTT was purchased from Sigma (batch number: MTBF7873V); LDH (lactate dehydrogenase) detection kit was purchased from Nanjing Jiancheng Institute of Bioengineering; Tunel detection kit was purchased from Promega, USA (batch number: 0000073091). Inactivated fetal bovine serum (batch number: 111023) was purchased from Hangzhou Sijiqing Bioengineering Materials Co., Ltd.; horse serum (batch number: 841843), DMEM medium (batch number: 823186) and MEM medium (batch number: 793870) were purchased from From Gibco; other reagents were of analytica...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of pharmacy, and particularly relates to an application of danshinolic acid A in preparation of medicines for preventing and treating AIDS encephalopathy as well as nerve damages caused by an HIV-1Tat protein. According to the invention, an HIV-1Tat protein damage type nerve cell line PC 12 and nerve cells on mouse brain slices are protected by using danshinolic acid A with different concentrations, and the effect of reducing the death of the nerve cells caused by the Tat protein of the danshinolic acid A is respectively detected by an MTT experiment, LDH detection and a Tunnel experiment; and dendritic spines are labeled by scattering Dil gold particles, and the effect of reducing Tat protein damage synaptic connectivity of the danshinolic acid A is detected. Through statistical analysis of experimental results, the danshinolic acid A is found to have a good protection effect against damages of the nerve cells caused by the Tat protein and can be used for preparing the medicines for preventing and treating the nerve damages caused by the Tat protein as well as the AIDS encephalopathy.

Description

technical field [0001] The invention belongs to the field of pharmaceutical technology, and relates to a new application of salvianolic acid A, a water-soluble component of traditional Chinese medicine Salvia miltiorrhiza Application of protein-induced nerve injury drugs. Background technique [0002] AIDS encephalopathy, now also known as HIV-associated neurocognitive disorders (HAND, HIV-associated neurocognitive disorders), is characterized by motor, behavioral and cognitive impairments, and has recently been divided into three forms according to the severity of the disease: asymptomatic neurocognitive disorders Cognitive impairment (Asymptomatic neurocognitive impairment, ANI), mild neurocognitive disorder (mild neurocognitive disorder, MND) and HIV-associated dementia (HIV associated dementia, HAD). [0003] The detailed mechanism of HIV-1 causing nerve damage remains to be further studied, but it is certain that the neurotoxic protein of HIV-1 damages neurons directly...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/216A61P31/18A61P25/00
Inventor 刘红亮王靖凯史朝晖胡磊刘彬邓锦波徐括喜
Owner HENAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com